Reported Jun 10, 2026 · Ongoing
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc.,…
Lannett Company Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lannett Company Inc. · 1101 C Ave W · Seymour, IN · 47274-3342
Is this the product you have?
- Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only
- Distributed byLannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46
- Lot codes and dates
Lot #: 25282724AExp. Date 2027/01
- Amount recalled
- 3984 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lannett Company Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.